International Journal of Women's Health and Reproduction Sciences

Home Aim and Scope Instructions to Authors Editorial Policies Editorial Board Authorship Agreement Form Open Access and Copyright

Jan 2017, Vol 5, Issue 1

CURRENT ISSUE ARCHIVE AHEAD OF PRINT / ACCEPTED ARTICLE MOST VIEWED ARTICLES NEWS RELATED LINKS

Advanced Search

For Author's & Reviewer's

Poll

How do you find the scientific quality of the published articles on our web site?

Very good

Good

Fair

Bad

Very bad

Review
Substance Use and Preconception Care: A Review of the Literature
Nila Ricks¹, Louise Comer², Fuqin Liu², Heather DeGrande², Olusola Adeniran²
¹Texas Woman?s University, Denton, Texas, USA ²College of Nursing, Texas Woman?s University, Denton, Texas, USA
IJWHR 2017; 5: 03-10 Viewed : 4781 times Downloaded : 5041 times. Keywords : Preconception care, Substance use, Pre-pregnancy health
Full Text(PDF) \| Related Articles
Abstract

Substance use has detrimental effects on reproductive health, especially on pregnancy outcomes. In this paper, we review the literature on substance use among both men and women during the preconception period. Preconception care (PCC) is increasingly recognized as a vital component of optimal maternal and infant health outcomes. The US Centers for Disease Control and Prevention (CDC) issued recommendations of PCC that include risk reduction before conception. There is a gap in the literature regarding substance use during the preconception period, however, as the emphasis on risk reduction before conception has focused mainly on women and selected substances. Further, there is a need to understand the existing evidence on substance use related disparity issues such as who has the highest prevalence, who has the worse effects, and who is least likely to get screened and treated. An understanding of these disparity issues is critical to effective PCC and optimal pregnancy outcomes.